PENNSYLVANIA Veterinary Disclosure Bill SB 768 Regular Session 2011-2012 Senate Bill 768 P.N. 782 has been filed by Senator Michael J. Stack and referred to the Senate Consumer Protection Committee. Please contact the Committe Chair
Robert M. Tomlinson rtomlinson@pasen.gov (717) 787-5072 and ask his committee to vote that this bill
"OUGHT TO PASS."
PERMISSION GRANTED TO CROSS-POST
All Committee members are listed below, if your Senator is on the list, please contact them as well as Senator Tomlinson.
Robert M. Tomlinson, Chair
rtomlinson@pasen.gov (717) 787-5072
John R. Gordner, Vice-Chair
jgordner@pasen.gov (717) 787-8928
Lisa M. Boscola, Minority Chair
boscola@pasenate.com (717) 787-4236
John B. Scarnati
jscarnati@pasen.gov (717) 787-7084
Edwin B. Erickson
eerickson@pasen.gov (717) 787-1350
Stewart J. Greenleaf
sgreenleaf@pasen.gov (717) 787-6599
Jeffrey E. Piccola
jpiccola@pasen.gov (717) 787-6801
John C. Rafferty, Jr.
jrafferty@pasen.gov (717) 787-1398
Kim L. Ward
kward@pasen.gov (717) 787-6063
Mary Jo White
mwhite@pasen.gov (717) 787-9684
Jim Ferlo
ferlo@pasenate.com (717) 787-6123
Richard A. Kasunic (717) 787-7175
Timothy J. Solobay (717) 787-1463
John N. Wozniak
wozniak@pasenate.com (717) 787-5400
"Veterinarians May Have to Provide New Information to Clients" DVM Newsmagazine 5/1/11
Veterinarians may have to provide new information to clients - DVM Text of SB 768 Regular Session 2011-2012 Senate Bill 768 P.N. 782
and (vi)
12
the veterinarian provides a client information sheet to the
13
owner of the animal in cases of dispensing prescription drugs
14
that will be administered by the owner in an outpatient setting.
15
(16) "Client information sheet" means a paper required by
16
the Center for Veterinary Medicine of the Food and Drug
17
Administration for the purpose of communicating important risk
18
information to clients and that is given to a veterinarian by a
19
prescription drug manufacturer so that owners of an animal are
20
provided with vital product safety information including
21
precautions, contraindications, signs of a possible adverse
22
reaction and steps to take in the event of an adverse reaction
23
to the prescription drug.